A Murine Model of Cholesteatoma‐Induced Bone Resorption Using Autologous Dermal Implantation
Holger Sudhoff, Yvonne Liebehenz, Jessica Aschenbrenner, Jae Hyun Jung, H. Hildmann, Stefan Dazert
Abstract
Holger Sudhoff, Yvonne Liebehenz, Jessica Aschenbrenner, Jae Hyun Jung, H. Hildmann, Stefan Dazert
Abstract
OBJECTIVE: To investigate a novel murine model for dermal implant-induced osteolysis analogous to bone resorption observed in middle ear cholesteatoma. STUDY DESIGN: Animal experiment. METHODS: We placed autologous dermal implants on the surface of mouse calvaria. The calvaria were examined at days 1, 3, 5, 7, and 14 after implantation by histological study and tartrate-resistant acid phosphatase immunohistochemical processing to detect osteoclasts. RESULTS: Dermal implants showed a significantly increased osteoclast density compared with control samples. The dermal implant tissue remained viable and produced a robust, localized inflammatory osteolytic response on the adjacent calvarial surface. Osteoclasts were predominantly found on the surface of the calvarium with the greatest osteoclast density seen at 5 to 7 days after implantation. CONCLUSION: The mouse model is expected to be a useful tool for investigating the pathogenesis of localized inflammatory bone resorption related to cholesteatoma.
OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate a novel murine model for dermal implant-induced osteolysis analogous to bone resorption observed in middle ear cholesteatoma. STUDY DESIGN: Animal experiment. METHODS: We placed autologous dermal implants on the surface of mouse calvaria. The calvaria were examined at days 1, 3, 5, 7, and 14 after implantation by histological study and tartrate-resistant acid phosphatase immunohistochemical processing to detect osteoclasts. RESULTS: Dermal implants showed a significantly increased osteoclast density compared with control samples. The dermal implant tissue remained viable and produced a robust, localized inflammatory osteolytic response on the adjacent calvarial surface. Osteoclasts were predominantly found on the surface of the calvarium with the greatest osteoclast density seen at 5 to 7 days after implantation. CONCLUSION: The mouse model is expected to be a useful tool for investigating the pathogenesis of localized inflammatory bone resorption related to cholesteatoma.
Key concepts: Calvaria, Cholesteatoma, Resorption, Osteolysis, Osteoclast, Bone resorption, Implant, Tartrate-resistant acid phosphatase